Hyperviscosity Syndrome in Paraprotein Secreting Conditions Including Waldenstrom Macroglobulinemia

Hyperviscosity Syndrome in Paraprotein Secreting Conditions Including Waldenstrom Macroglobulinemia

Hyperviscosity syndrome is a serious complication associated with high levels of paraproteins in patients with hematological malignancies. Therapeutic advances in disease control may reduce the incidence of hyperviscosity syndrome; however, management of acute cases requires an understanding of key...

Full description

Bibliographic Details
Main Authors: Allison Weaver, Samuel Rubinstein, Robert F. Cornell
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Oncology
Subjects:
hyperviscosity
plasma exchange
Waldenstrom
lymphoma
chemotherapy
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00815/full
id doaj-a5f6ff3aba2945869ac521e29eab5b1d
record_format Article
spelling doaj-a5f6ff3aba2945869ac521e29eab5b1d2020-11-25T03:32:05ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-05-011010.3389/fonc.2020.00815532645Hyperviscosity Syndrome in Paraprotein Secreting Conditions Including Waldenstrom MacroglobulinemiaAllison WeaverSamuel RubinsteinRobert F. CornellHyperviscosity syndrome is a serious complication associated with high levels of paraproteins in patients with hematological malignancies. Therapeutic advances in disease control may reduce the incidence of hyperviscosity syndrome; however, management of acute cases requires an understanding of key symptoms and prompt treatment to mitigate serious consequences.https://www.frontiersin.org/article/10.3389/fonc.2020.00815/fullhyperviscosityplasma exchangeWaldenstromlymphomachemotherapy
collection DOAJ
language English
format Article
sources DOAJ
author Allison Weaver
Samuel Rubinstein
Robert F. Cornell
spellingShingle Allison Weaver
Samuel Rubinstein
Robert F. Cornell
Hyperviscosity Syndrome in Paraprotein Secreting Conditions Including Waldenstrom Macroglobulinemia
Frontiers in Oncology
hyperviscosity
plasma exchange
Waldenstrom
lymphoma
chemotherapy
author_facet Allison Weaver
Samuel Rubinstein
Robert F. Cornell
author_sort Allison Weaver
title Hyperviscosity Syndrome in Paraprotein Secreting Conditions Including Waldenstrom Macroglobulinemia
title_short Hyperviscosity Syndrome in Paraprotein Secreting Conditions Including Waldenstrom Macroglobulinemia
title_full Hyperviscosity Syndrome in Paraprotein Secreting Conditions Including Waldenstrom Macroglobulinemia
title_fullStr Hyperviscosity Syndrome in Paraprotein Secreting Conditions Including Waldenstrom Macroglobulinemia
title_full_unstemmed Hyperviscosity Syndrome in Paraprotein Secreting Conditions Including Waldenstrom Macroglobulinemia
title_sort hyperviscosity syndrome in paraprotein secreting conditions including waldenstrom macroglobulinemia
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2020-05-01
description Hyperviscosity syndrome is a serious complication associated with high levels of paraproteins in patients with hematological malignancies. Therapeutic advances in disease control may reduce the incidence of hyperviscosity syndrome; however, management of acute cases requires an understanding of key symptoms and prompt treatment to mitigate serious consequences.
topic hyperviscosity
plasma exchange
Waldenstrom
lymphoma
chemotherapy
url https://www.frontiersin.org/article/10.3389/fonc.2020.00815/full
work_keys_str_mv AT allisonweaver hyperviscositysyndromeinparaproteinsecretingconditionsincludingwaldenstrommacroglobulinemia
AT samuelrubinstein hyperviscositysyndromeinparaproteinsecretingconditionsincludingwaldenstrommacroglobulinemia
AT robertfcornell hyperviscositysyndromeinparaproteinsecretingconditionsincludingwaldenstrommacroglobulinemia
_version_ 1724569795839393792

Similar Items